Nuance Investments’s Intersect ENT, Inc XENT Stock Holding History

Nuance Investments’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-573,259	Closed	-$16.1M	–	62
2022 Q1	$16.1M	Sell	573,259 -3,733	-0.6%	-$102K	0.29%	41
2021 Q4	$15.8M	Buy	576,992 +108,438	+23%	+$2.94M	0.28%	47
2021 Q3	$12.7M	Buy	+468,554	New	+$11.6M	0.23%	49

Nuance Investments's XENT Position: Q2 2022 in Review

Nuance Investments sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 573,259 shares — an estimated $16.1M sold.

Nuance Investments first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $16.1M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Nuance Investments reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Nuance Investments sold 573,259 Intersect ENT, Inc shares in Q2 2022, an estimated $16.1M.
Nuance Investments first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Nuance Investments's Intersect ENT, Inc position peaked at $16.1M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Nuance Investments's 13F filing for Q2 2022, filed 8 Aug 2022.